Interactions of (R)-roscovitine with PDXK (A and B) and CDK2 (C and D).... | Download Scientific Diagram
Roscovitine has anti-proliferative and pro-apoptotic effects on glioblastoma cell lines: A pilot study
Structural analogues of roscovitine rescue the intracellular traffic and the function of ER-retained ABCB4 variants in cell models | Scientific Reports
Frontiers | Targeting Cyclin-Dependent Kinases for Treatment of Gynecologic Cancers | Oncology
Seliciclib - Wikipedia
Kinase inhibitor roscovitine as a PB2 cap-binding inhibitor against influenza a virus replication - ScienceDirect
R)-Roscovitine and CFTR modulators enhance killing of multi-drug resistant Burkholderia cenocepacia by cystic fibrosis macrophages | Scientific Reports
Mechanism of action of novel medical treatments for Cushing's disease.... | Download Scientific Diagram
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. - Abstract - Europe PMC
From Roscovitine to CYC202 to Seliciclib – from bench to bedside: discovery and development
Roscovitine (Seliciclib,CYC202) | CAS:186692-46-6 | CDK inhibitor,potent and selective | High Purity | Manufacturer BioCrick
R-Roscovitine Improves Motoneuron Function in Mouse Models for Spinal Muscular Atrophy - ScienceDirect
Roscovitine attenuates intimal hyperplasia via inhibiting NF-κB and STAT3 activation induced by TNF-α in vascular smooth muscle cells - ScienceDirect
![An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors - Molecular BioSystems (RSC Publishing) DOI:10.1039/C3MB70186G](https://pubs.rsc.org/image/article/2013/MB/c3mb70186g/c3mb70186g-f11.gif "An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors - Molecular BioSystems (RSC Publishing) DOI:10.1039/C3MB70186G")
An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors - Molecular BioSystems (RSC Publishing) DOI:10.1039/C3MB70186G
Roscovitine induces up-regulation of both pro-and antiapoptotic BCL-2... | Download Scientific Diagram
Frontiers | CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas | Pharmacology
Roscovitine and neutrophils. a The different steps of inflammation:... | Download Scientific Diagram
![PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bb30ac1cbae5709f3c8e813bcc2da77ce6b5f3cd/3-Figure2-1.png "PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar")
PDF] CR8, a potent and selective, roscovitine-derived inhibitor of cyclin-dependent kinases | Semantic Scholar
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis. - Abstract - Europe PMC
Frontiers | Playing the Whack-A-Mole Game: ERK5 Activation Emerges Among the Resistance Mechanisms to RAF-MEK1/2-ERK1/2- Targeted Therapy | Cell and Developmental Biology
Model depicting mechanism of action of R-Roscovitine and its inhibition... | Download Scientific Diagram
New Insights into CDK Regulators: Novel Opportunities for Cancer Therapy: Trends in Cell Biology
